Company intelligence / Profile preview

ANKON Technologies

Ownership: Private
Employees: ~251
Development stage: Commercial

Overview

ANKON commercialized the world’s first magnetically controlled capsule endoscope system, enabling non-invasive, painless, and comprehensive gastric examinations. The NaviCam system is approved by China NMPA, CE marked in Europe, and received De Novo classification from the US FDA. It is widely used in hundreds of hospitals across China and exported internationally.

Therapeutic areas: Gastroenterology
Modalities: DeviceRobotic capsule endoscopy system
Industry: Medical Imaging

Drug pipeline

3 assets

NaviCam Small Bowel System

Commercial

Indications: Small bowel diseases

2 more assets in the full pipeline.

Request access →

Partnerships

AnX Robotica (commercialization/distribution partnership for US market)

Beyond the preview

Go deeper on ANKON Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKON Technologies.

Explore the full profile